This protocol is judged by an institutional evaluate board, an independent team that testimonials any medical trials involving individuals. If a review requires a Plan I drug, after the board approves the protocol as ethical, the scientists need to apply for an investigational new drug (IND) quantity through the FDA.Weiser urged social media market